Financing round completed
Posted onQvanteq AG completed a financing round. It provides the company with sufficient cash to further develop its technology for vascular stents such as intracranial stents and flow diverters.
Qvanteq AG completed a financing round. It provides the company with sufficient cash to further develop its technology for vascular stents such as intracranial stents and flow diverters.
In vivo data involving Qvanteq’s surface technology was published in the April issue of the journal Eurointervention.